235
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan

, , , &
Pages 643-650 | Accepted 29 Dec 2010, Published online: 21 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hitoshi Ishii. (2012) Development and Psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) Questionnaire. Journal of Medical Economics 15:3, pages 556-563.
Read now

Articles from other publishers (9)

Aurore Lesage, Brice Leclère, Leïla Moret & Clément Le Glatin. (2021) Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies. PLOS ONE 16:1, pages e0245112.
Crossref
Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Akira Yamauchi, Yasuhiko Kanazawa, Yoshiaki Okubo, Mikiya Tokui, Takatoshi Imai, Rie Murakami, Tami Tsuchiya, Hironobu Sasaki, Tatsuhiro Masaoka, Junichiro Irie, Shu Meguro & Hiroshi Itoh. (2019) Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes. Journal of Diabetes Investigation 11:2, pages 382-388.
Crossref
Hitoshi Ishii, Tetsuji Niiya, Yasuhiro Ono, Naoyuki Inaba, Hideaki Jinnouchi & Hirotaka Watada. (2017) Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetology & Metabolic Syndrome 9:1.
Crossref
Marcin Czech, Elżbieta Rdzanek, Justyna Pawęska, Olga Adamowicz-Sidor, Maciej Niewada & Michał Jakubczyk. (2015) Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis. BMC Endocrine Disorders 15:1.
Crossref
Seiji Sato, Yoshifumi Saisho, Kinsei Kou, Shu Meguro, Masami Tanaka, Junichiro Irie, Toshihide Kawai & Hiroshi Itoh. (2015) Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial. PLOS ONE 10:3, pages e0121988.
Crossref
Kumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, Masami Tanaka, Shu Meguro, Junichiro Irie, Takatoshi Imai, Toshikatsu Shigihara, Jiro Morimoto, Ken Yajima, Yoshihito Atsumi, Izumi Takei & Hiroshi Itoh. (2015) Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes. Endocrine Journal 62:5, pages 399-409.
Crossref
Hitoshi Ishii, Yasuo Terauchi, Hideaki Jinnouchi, Masanori Taketsuna, Masakazu Takeuchi & Takeshi Imaoka. (2013) Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual c. Journal of Diabetes Investigation 4:6, pages 560-570.
Crossref
Kyriakos Aloumanis, Marianna Benroubi, Sotiria Sourmeli & Vangelis Drossinos. (2013) Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: Two-year experience from the INSTIGATE study. Primary Care Diabetes 7:3, pages 235-242.
Crossref
Andreas Liebl, Vinay Prusty, Paul Valensi, Ryuzo Kawamori, Jens Sandahl Christiansen, Andrew J. Palmer, Per Balschmidt, Robert Ligthelm & Viswanathan Mohan. (2012) Ten Years of Experience with Biphasic Insulin Aspart 30. Drugs 72:11, pages 1495-1520.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.